Effects of the Use of Adjuvant Drugs After Extracorporeal Shockwave Lithotripsy (ESWL) in Renal Calculus
Effect of Tamsulosin and Nifedipine on the Elimination of Fragments After Extracorporeal Shock Waves Lithotripsy in Patients With Kidney Stones - a Prospective, Double-blind and Randomized Study
1 other identifier
interventional
136
1 country
1
Brief Summary
The investigators objective is to study if some drugs can improve the success rate of extracorporeal shockwave lithotripsy for renal stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Aug 2006
Typical duration for phase_3
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 5, 2010
CompletedFirst Posted
Study publicly available on registry
October 6, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedOctober 6, 2010
September 1, 2010
3.8 years
October 5, 2010
October 5, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To evaluate the effects of Tamsulosin and Nifedipine in the success rates after treatment of radiopaque renal stones between 5-20 mm with only one session of SWL
30 days
Secondary Outcomes (2)
To evaluate the effects of Tamsulosin and Nifedipine in the episodes of pain after treatment of radiopaque renal stones between 5-20 mm with only one session of SWL
30 days
To evaluate the effects of Tamsulosin and Nifedipine in the velocity of elimination of fragments after treatment of radiopaque renal stones between 5-20 mm with only one session of SWL
30 days
Study Arms (3)
Nifedipine
ACTIVE COMPARATORnifedipine retard 20mg daily
tamsulosin
ACTIVE COMPARATORtamsulosin 0,4mg
placebo
PLACEBO COMPARATORplacebo capsule
Interventions
tamsulosin 0,4mg every night for 30 consecutive days
Eligibility Criteria
You may qualify if:
- radiopaque renal stone, 5 to 20 mm, located at renal pelvis or superior or middle calix
You may not qualify if:
- inferior calix, any contraindication for extracorporeal shockwave lithotripsy, pregnancy, coagulopathy, previous renal surgery, age under 18, abdominal aorta aneurism and urinary infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinics Hospital of University of Sao Paulo
São Paulo, São Paulo, 05403900, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Miguel Srougi, MD
University of Sao Paulo
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 5, 2010
First Posted
October 6, 2010
Study Start
August 1, 2006
Primary Completion
June 1, 2010
Study Completion
December 1, 2010
Last Updated
October 6, 2010
Record last verified: 2010-09